Efficacy and Safety of Hizentra®, a New 20% Immunoglobulin Preparation for Subcutaneous Administration, in Pediatric Patients with Primary Immunodeficiency
Title:
Efficacy and Safety of Hizentra®, a New 20% Immunoglobulin Preparation for Subcutaneous Administration, in Pediatric Patients with Primary Immunodeficiency
Author:
Borte, Michael Pac, Malgorzata Serban, Margit Gonzalez-Quevedo, Teresa Grimbacher, Bodo Jolles, Stephen Zenker, Othmar Neufang-Hueber, Jutta Belohradsky, Bernd